What criteria did the committee use to determine which studies to include in their review for the 2018 NICE Chronic Heart Failure Guideline?
The committee discussed the protocol for this review question and agreed that the previously included studies which had a population of people with heart failure post myocardial infarction were not appropriate for consideration within the review. In addition to this, the committee agreed that the minimum duration of follow-up for included studies should be 6 months and have a minimum sample size of 100 to ensure an accurate clinical effect can be established. In addition to this, the committee agreed that cross-over studies should be excluded to ensure that potential carryover effects are not confounding the outcome.